Byotrol plc develops and commercialize antimicrobial technologies and products in the United Kingdom, North America, and internationally. The company operates through Professional and Consumer segments. Its product portfolio includes Actizone, a antimicrobial technology which improves cleaning performance and long-lasting protection against bacteria; and Byotrol, a long-lasting antimicrobial protection for various applications including bathroom cleaners to multi-surface wipes. The company also offers HLD4, a broad-spectrum disinfectant designed for high soil environments of the animal health sector; and Invirtu for skin care. It serves human and animal health, facilities management, food and beverages, household, and skin and pet care markets. The company was incorporated in 2005 and is headquartered in Chester, the United Kingdom.
Visit company website
5 years, 5 months ago
Byotrol plc is currently in a long term downtrend where the price is trading 11.4% below its 200 day moving average.
From a valuation standpoint, the stock is 99.9% cheaper than other stocks from the Consumer Defensive sector with a price to sales ratio of 2.5.
Byotrol plc's total revenue sank by 0.0% to $1M since the same quarter in the previous year.
Its net income has dropped by 0.0% to $-318K since the same quarter in the previous year.
Finally, its free cash flow grew by 197.7% to $272K since the same quarter in the previous year.
Based on the above factors, Byotrol plc gets an overall score of 2/5.